Literature DB >> 21110319

Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties.

Venkatesh L Hegde1, Mitzi Nagarkatti, Prakash S Nagarkatti.   

Abstract

Cannabinoid receptor activation by agents such as Δ(9)-tetrahydrocannabinol (THC) is known to trigger immune suppression. Here, we show that administration of THC in mice leads to rapid and massive expansion of CD11b(+)Gr-1(+) myeloid-derived suppressor cells (MDSC) expressing functional arginase and exhibiting potent immunosuppressive properties both in vitro and in vivo. The induction of MDSC by THC was associated with a significant increase in granulocyte CSF. Moreover, administration of anti-granulocyte CSF Ab inhibited the induction of MDSC by THC. THC was able to induce MDSC in TLR4 mutant C3H and C57BL10/ScN mice and hence acted independently of TLR4. Accumulation of MDSC in the periphery with a corresponding decrease in the proportion of CD11b(+)Gr-1(+) cells in the bone marrow, as well as in vivo BrdU labeling and cell-cycle analysis, showed that THC induced mobilization of these cells from bone marrow and their expansion in the periphery. Use of selective antagonists SR141716A and SR144528 against cannabinoid receptors 1 and 2, respectively, as well as receptor-deficient mice showed that induction of MDSC was mediated through activation of both cannabinoid receptors 1 and 2. These studies demonstrate that cannabinoid receptor signaling may play a crucial role in immune regulation via the induction of MDSC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21110319      PMCID: PMC3076065          DOI: 10.1002/eji.201040667

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  50 in total

1.  Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion.

Authors:  Anne-Sophie Dugast; Thomas Haudebourg; Flora Coulon; Michèle Heslan; Fabienne Haspot; Nicolas Poirier; Romain Vuillefroy de Silly; Claire Usal; Helga Smit; Bernard Martinet; Pamela Thebault; Karine Renaudin; Bernard Vanhove
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

2.  Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells.

Authors:  Giovanna Gallina; Luigi Dolcetti; Paolo Serafini; Carmela De Santo; Ilaria Marigo; Mario P Colombo; Giuseppe Basso; Frank Brombacher; Ivan Borrello; Paola Zanovello; Silvio Bicciato; Vincenzo Bronte
Journal:  J Clin Invest       Date:  2006-10       Impact factor: 14.808

3.  Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host.

Authors:  Cunren Liu; Shaohua Yu; John Kappes; Jianhua Wang; William E Grizzle; Kurt R Zinn; Huang-Ge Zhang
Journal:  Blood       Date:  2007-01-23       Impact factor: 22.113

4.  CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress.

Authors:  Valeriya P Makarenkova; Vishal Bansal; Benjamin M Matta; Lori Ann Perez; Juan B Ochoa
Journal:  J Immunol       Date:  2006-02-15       Impact factor: 5.422

5.  Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria.

Authors:  Wentao Jia; Venkatesh L Hegde; Narendra P Singh; Daniel Sisco; Steven Grant; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Mol Cancer Res       Date:  2006-08       Impact factor: 5.852

6.  A common pathway mediated through Toll-like receptors leads to T- and natural killer-cell immunosuppression.

Authors:  Ilan Vaknin; Liora Blinder; Lynn Wang; Roi Gazit; Elena Shapira; Olga Genina; Mark Pines; Eli Pikarsky; Michal Baniyash
Journal:  Blood       Date:  2007-11-08       Impact factor: 22.113

7.  Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells.

Authors:  Pratima Sinha; Virginia K Clements; Amy M Fulton; Suzanne Ostrand-Rosenberg
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

8.  Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity.

Authors:  Kiavash Movahedi; Martin Guilliams; Jan Van den Bossche; Rafael Van den Bergh; Conny Gysemans; Alain Beschin; Patrick De Baetselier; Jo A Van Ginderachter
Journal:  Blood       Date:  2008-02-13       Impact factor: 22.113

9.  Dose translation from animal to human studies revisited.

Authors:  Shannon Reagan-Shaw; Minakshi Nihal; Nihal Ahmad
Journal:  FASEB J       Date:  2007-10-17       Impact factor: 5.191

10.  MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis.

Authors:  Matthew J Delano; Philip O Scumpia; Jason S Weinstein; Dominique Coco; Srinivas Nagaraj; Kindra M Kelly-Scumpia; Kerri A O'Malley; James L Wynn; Svetlana Antonenko; Samer Z Al-Quran; Ryan Swan; Chun-Shiang Chung; Mark A Atkinson; Reuben Ramphal; Dmitry I Gabrilovich; Wesley H Reeves; Alfred Ayala; Joseph Phillips; Drake Laface; Paul G Heyworth; Michael Clare-Salzler; Lyle L Moldawer
Journal:  J Exp Med       Date:  2007-06-04       Impact factor: 14.307

View more
  50 in total

1.  Perinatal exposure to Δ9-tetrahydrocannabinol triggers profound defects in T cell differentiation and function in fetal and postnatal stages of life, including decreased responsiveness to HIV antigens.

Authors:  Catherine Lombard; Venkatesh L Hegde; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  J Pharmacol Exp Ther       Date:  2011-08-10       Impact factor: 4.030

2.  Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1.

Authors:  Austin R Jackson; Venkatesh L Hegde; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Leukoc Biol       Date:  2013-12-06       Impact factor: 4.962

3.  Distinct microRNA expression profile and targeted biological pathways in functional myeloid-derived suppressor cells induced by Δ9-tetrahydrocannabinol in vivo: regulation of CCAAT/enhancer-binding protein α by microRNA-690.

Authors:  Venkatesh L Hegde; Sunil Tomar; Austin Jackson; Roshni Rao; Xiaoming Yang; Udai P Singh; Narendra P Singh; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Biol Chem       Date:  2013-11-07       Impact factor: 5.157

4.  Δ⁹-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells.

Authors:  Jessica M Sido; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Leukoc Biol       Date:  2015-06-01       Impact factor: 4.962

5.  Role of resveratrol-induced CD11b(+) Gr-1(+) myeloid derived suppressor cells (MDSCs) in the reduction of CXCR3(+) T cells and amelioration of chronic colitis in IL-10(-/-) mice.

Authors:  Udai P Singh; Narendra P Singh; Balwan Singh; Lorne J Hofseth; Dennis D Taub; Robert L Price; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Brain Behav Immun       Date:  2011-07-23       Impact factor: 7.217

6.  Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: evidence from an experimental murine model.

Authors:  Rupal Pandey; Venkatesh L Hegde; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  J Pharmacol Exp Ther       Date:  2011-06-14       Impact factor: 4.030

7.  Histone modifications are associated with Δ9-tetrahydrocannabinol-mediated alterations in antigen-specific T cell responses.

Authors:  Xiaoming Yang; Venkatesh L Hegde; Roshni Rao; Jiajia Zhang; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Biol Chem       Date:  2014-05-19       Impact factor: 5.157

8.  Cannabinoid Receptor 2 Modulates Susceptibility to Experimental Cerebral Malaria through a CCL17-dependent Mechanism.

Authors:  Judith Alferink; Sabine Specht; Hannah Arends; Beatrix Schumak; Kim Schmidt; Christina Ruland; Ramona Lundt; Andrea Kemter; Andrea Dlugos; Janina M Kuepper; Karola Poppensieker; Matthias Findeiss; Önder Albayram; David-M Otte; Janine Marazzi; Jürg Gertsch; Irmgard Förster; Wolfgang Maier; Stefanie Scheu; Achim Hoerauf; Andreas Zimmer
Journal:  J Biol Chem       Date:  2016-07-29       Impact factor: 5.157

9.  Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.

Authors:  Venkatesh L Hegde; Udai P Singh; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

10.  Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders.

Authors:  Dario Siniscalco; Anna Sapone; Catia Giordano; Alessandra Cirillo; Laura de Magistris; Francesco Rossi; Alessio Fasano; James Jeffrey Bradstreet; Sabatino Maione; Nicola Antonucci
Journal:  J Autism Dev Disord       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.